Amphastar Pharmaceuticals, Inc. (AMPH)
26.84
+0.38
(+1.46%)
USD |
NASDAQ |
Dec 24, 12:59
26.82
-0.02
(-0.06%)
After-Hours: 13:59
Amphastar Pharmaceuticals SG&A Expense (TTM): 126.42M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 10.39B |
| Align Technology, Inc. | 1.739B |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| CorMedix, Inc. | 75.56M |
| Supernus Pharmaceuticals, Inc. | 442.58M |